Elevate Your Brand to the Forefront of ASIT in 2026
If you are seeking to position your organization at the forefront of the ASIT ecosystem, whether your advancing clinical development, scaling an emerging biotech, or providing enabling services or solutions, this meeting offers a premier platform to elevate your visibility and showcase your leadership to a global audience.
As the field rapidly matures, developers must navigate complex translation challenges for nearly a decade, this summit has enabled direct engagement with key stakeholders making strategic investment and partnership decisions, giving you the opportunity to showcase your capabilities, build credibility, and help shape future therapeutic direction.
With 100+ senior stakeholders from leading pharmaceutical and biotechnology organizations in attendance, such as Topas Therapeutics, COUR, Tscan and Pfizer, facilitate meaningful, targeted discussions with individuals actively shaping the ASIT pipeline.
What to Expect?
Accelerate Strategic Partnerships
ASIT developers are actively seeking collaborators who can help overcome core barriers, including validating novel antigens, enhancing biomarker sensitivity, demonstrating mechanism of action, de-risking early trials, and navigating evolving regulatory pathways. This summit provides a uniquely concentrated forum to showcase how your solutions directly address these real-world challenges.
Engage High-Intent Drug Developers
Join 100+ senior experts from Pfizer, AbbVie, Moderna, COUR, Diamyd, Topas, Parvus and more, looking to evaluate new platforms, technologies, and services to support discovery, translation, and clinical advancement. Engage decision-makers at this critical stage in field development.
Align With Fast-Moving Innovators
As mRNA-LNP, nanoparticle systems, Treg therapies, and gene-edited cellular approaches move toward first-in-human studies, organizations increasingly require partners with translational, CMC and regulatory expertise. This forum spotlights your ability to guide and enable that growth whilst gaining market intelligence of the latest innovations.
Key Interest Areas
Our attendees are looking for service and solution providers with capabilities in the below areas but not limited to:
1
Biopharmaceutical Partnership Opportunities
2
Immunophenotyping & Assay Strategy
3
Biomarker Identification & Validation
4
Stratified Targeted Patient Recruitment for Specialized Trials
5
Antigen Discovery Platforms
6
Human-Data In Vitro & In Vivo Models
Audience Composition
Attendee Seniority
Company Type
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverable such as badges, exclusive dinners and tours to help elevate your brand.
Presenting Slots
Data-driven or case study-led presentations to position yourself as a thought-leader.
Lead
Expert panels to shape forward-thinking discussions.
Full Delegate List
Gain exclusive access to the Full Delegate List to plan your conversations in advance.
Exhibit
Raise brand awareness and answer questions from prospect customers.
Network
Engage in 1-2-1 conversations with industry or be part of the organized networking options to generate commercial collaborations.
Innovative Networking
Host breakfast, lunches, dinners for drinks receptions to have exclusive time with your target audience.
Champion the Industry
Be part of the close-knit community and position yourself as an advocate for innovation and achievements in the ASIT field.
Branding
On-site and website branding to highlight your company at the forefront of the ASIT field.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Malik Mellal
Partnerships Director